• Home

  • Documents

  • Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
32
Radiopharmaceuticals in Metastatic Castration- Resistant Prostate Cancer

Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer

Embed Size (px)

DESCRIPTION

Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer. Program Goals. - PowerPoint PPT Presentation

Citation preview

Page 1: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer

Rationale for Radiopharmaceuticals in

Metastatic Castration-Resistant Prostate Cancer

Page 2: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer

Program Goals

Page 3: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 4: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 5: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 6: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 7: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 8: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 9: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 10: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 11: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 12: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 13: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 14: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 15: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 16: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 17: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 18: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 19: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 20: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 21: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 22: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 23: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 24: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 25: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 26: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 27: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 28: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 29: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 30: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 31: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer
Page 32: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer

A Clinical Trial for Metastatic Castration-Resistant ...prostatehealthed.org/images/11659_MK7339_010_5_5x8...Metastatic prostate cancer is cancer that has spread beyond the prostate

A Clinical Trial for Metastatic Castration-Resistant ...prostatehealthed.org/images/11659_MK7339_010_5_5x8...Metastatic prostate cancer is cancer that has spread beyond the prostate

Documents
Metastatic castration-resistant prostate cancer reveals intrapatient

Metastatic castration-resistant prostate cancer reveals intrapatient

Documents
1. Epic Sciences, La Jolla, CA; 2 ......sdfsdfsdf Study Population Molecular Characterization of Circulating Tumor Cells (CTCs) and CTC subpopulations in progressive metastatic Castration

1. Epic Sciences, La Jolla, CA; 2 ......sdfsdfsdf Study Population Molecular Characterization of Circulating Tumor Cells (CTCs) and CTC subpopulations in progressive metastatic Castration

Documents
A Clinical Trial for - Prostate Health Education Networkprostatehealthed.org/images/11658_MK3475_641_5_5x8... · A Clinical Trial for Metastatic Castration-Resistant Prostate Cancer

A Clinical Trial for - Prostate Health Education Networkprostatehealthed.org/images/11658_MK3475_641_5_5x8... · A Clinical Trial for Metastatic Castration-Resistant Prostate Cancer

Documents
Radiotherapy from within The Bone For Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Tony Wu. Department of Surgery, Kaohsiung Veterans

Radiotherapy from within The Bone For Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Tony Wu. Department of Surgery, Kaohsiung Veterans

Documents
Lessons learned from the metastatic castration-resistant prostate … · 2019. 2. 10. · Lessons learned from the metastatic castration-resistant prostate cancer phase 1 trial of

Lessons learned from the metastatic castration-resistant prostate … · 2019. 2. 10. · Lessons learned from the metastatic castration-resistant prostate cancer phase 1 trial of

Documents
Glucocorticoid Receptor Activity Contributes to Resistance ......metastatic PC is initially treated with castration-based thera-pies to eliminate testicular androgen production [18]

Glucocorticoid Receptor Activity Contributes to Resistance ......metastatic PC is initially treated with castration-based thera-pies to eliminate testicular androgen production [18]

Documents
pan-Canadian Oncology Drug Review Final Clinical …...pan-Canadian Oncology Drug Review Final Clinical Guidance Report Apalutamide (Erleada) for metastatic Castration Sensitive Prostate

pan-Canadian Oncology Drug Review Final Clinical …...pan-Canadian Oncology Drug Review Final Clinical Guidance Report Apalutamide (Erleada) for metastatic Castration Sensitive Prostate

Documents
Metastatic castration resistant prostate cancer: Current ... · castration resistant prostate cancer: Current strategies of management ... Recent advances have also led to an unprecedented

Metastatic castration resistant prostate cancer: Current ... · castration resistant prostate cancer: Current strategies of management ... Recent advances have also led to an unprecedented

Documents
Lutetium-177 PSMA Radioligand Therapy of Metastatic ......2016/01/20  · Lutetium-177 PSMA Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

Lutetium-177 PSMA Radioligand Therapy of Metastatic ......2016/01/20  · Lutetium-177 PSMA Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

Documents
Novel Agents in the Treatment of Metastatic Castration ... CRPC.pdf · Novel Agents in the Treatment of Metastatic Castration-Resistant ... Objectives • Evaluate the ... • Asses

Novel Agents in the Treatment of Metastatic Castration ... CRPC.pdf · Novel Agents in the Treatment of Metastatic Castration-Resistant ... Objectives • Evaluate the ... • Asses

Documents
Multi-disciplinary Team (MDT) Guidance for Managing ... · TURP: transurethral resection of the prostate CRPC: castration resistant prostate cancer mCRPC : metastatic castration resistant

Multi-disciplinary Team (MDT) Guidance for Managing ... · TURP: transurethral resection of the prostate CRPC: castration resistant prostate cancer mCRPC : metastatic castration resistant

Documents
Response to olaparib in metastatic castration-resistant ......CASE REPORT Open Access Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation:

Response to olaparib in metastatic castration-resistant ......CASE REPORT Open Access Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation:

Documents
Consultant Medical Oncologist Mahatma Gandhi Cancer ... · Metastatic castration sensitive prostate cancer Dr B. RakeshReddy MD DM ECMO Consultant Medical Oncologist Mahatma Gandhi

Consultant Medical Oncologist Mahatma Gandhi Cancer ... · Metastatic castration sensitive prostate cancer Dr B. RakeshReddy MD DM ECMO Consultant Medical Oncologist Mahatma Gandhi

Documents
Castration-Resistant Metastatic Prostate Cancer: Novel Therapeutics

Castration-Resistant Metastatic Prostate Cancer: Novel Therapeutics

Documents
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration ...jnm.snmjournals.org/content/60/4/517.full.pdf · Dosimetry of 177Lu-PSMA-617 in Metastatic Castration- Resistant Prostate Cancer:

Dosimetry of 177Lu-PSMA-617 in Metastatic Castration ...jnm.snmjournals.org/content/60/4/517.full.pdf · Dosimetry of 177Lu-PSMA-617 in Metastatic Castration- Resistant Prostate Cancer:

Documents
richtlijnendatabase.nl · Web viewAbiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall analysis of the COU-AA-301 randomised, double-blind,

richtlijnendatabase.nl · Web viewAbiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall analysis of the COU-AA-301 randomised, double-blind,

Documents
Palliative treatment of metastatic bone pain with radiopharmaceuticals… · 2017-03-04 · beyond Strontium-89 and Samarium-153 ... Palliative treatment of metastatic bone pain with

Palliative treatment of metastatic bone pain with radiopharmaceuticals… · 2017-03-04 · beyond Strontium-89 and Samarium-153 ... Palliative treatment of metastatic bone pain with

Documents
Abiraterone & Subsequent Enzalutamide Therapy in Metastatic Castration … · 2017. 12. 29. · Abiraterone & Subsequent Enzalutamide Therapy in Metastatic Castration-Resistant Prostate

Abiraterone & Subsequent Enzalutamide Therapy in Metastatic Castration … · 2017. 12. 29. · Abiraterone & Subsequent Enzalutamide Therapy in Metastatic Castration-Resistant Prostate

Documents
Statins in Metastatic Castration-Resistant Prostate Cancer · 2017. 6. 22. · Statins in Metastatic Castration-Resistant Prostate Cancer - Version 1.1 - 23 February 2017 Page 1 of

Statins in Metastatic Castration-Resistant Prostate Cancer · 2017. 6. 22. · Statins in Metastatic Castration-Resistant Prostate Cancer - Version 1.1 - 23 February 2017 Page 1 of

Documents
Predictors for progression of metastatic prostate cancer ...icmr.nic.in/ijmr/2016/May supplement/s512.pdf · Predictors for progression of metastatic prostate cancer to castration-

Predictors for progression of metastatic prostate cancer ...icmr.nic.in/ijmr/2016/May supplement/s512.pdf · Predictors for progression of metastatic prostate cancer to castration-

Documents
Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

Education
The Role of AR-V7 in the Management of Metastatic ... · The Role of AR-V7 in the Management of Metastatic Castration -Resistant Prostate Cancer Deborah Davison, DNP Associate Director,

The Role of AR-V7 in the Management of Metastatic ... · The Role of AR-V7 in the Management of Metastatic Castration -Resistant Prostate Cancer Deborah Davison, DNP Associate Director,

Documents
Metastatic castration resistant prostate cancer (mCRPC) · Prostate Cancer: Castration resistant (CRPC) ADT: Androgen Deprivation Therapy M0: By imaging no evidence of metastases

Metastatic castration resistant prostate cancer (mCRPC) · Prostate Cancer: Castration resistant (CRPC) ADT: Androgen Deprivation Therapy M0: By imaging no evidence of metastases

Documents
Appraisal of Recent Progress in Metastatic Castration-Resistant Prostate Cancer

Appraisal of Recent Progress in Metastatic Castration-Resistant Prostate Cancer

Education
Lutetium-177 PSMA Radioligand Therapy of Metastatic ...jnm.snmjournals.org/content/early/2016/01/20/jnumed.115.168443... · Lutetium-177 PSMA Radioligand Therapy of Metastatic Castration-Resistant

Lutetium-177 PSMA Radioligand Therapy of Metastatic ...jnm.snmjournals.org/content/early/2016/01/20/jnumed.115.168443... · Lutetium-177 PSMA Radioligand Therapy of Metastatic Castration-Resistant

Documents
Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer Clinical Practice Guideline

Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer Clinical Practice Guideline

Documents
Immunotherapy and Bone-Metastatic Castration-Resistant ...Prostate cancer epithelial cells typically proliferate in response to sex hormones called androgens, which include testosterone

Immunotherapy and Bone-Metastatic Castration-Resistant ...Prostate cancer epithelial cells typically proliferate in response to sex hormones called androgens, which include testosterone

Documents
Treatment of Metastatic Castration Resistant Prostate Cancer · Treatment of Metastatic Castration Resistant Prostate Cancer Ravi A. Madan, MD Clinical Director Genitourinary Malignancies

Treatment of Metastatic Castration Resistant Prostate Cancer · Treatment of Metastatic Castration Resistant Prostate Cancer Ravi A. Madan, MD Clinical Director Genitourinary Malignancies

Documents
RL Prostaat - PICO 2 - Methodology report€¦ · Web viewAbiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of

RL Prostaat - PICO 2 - Methodology report€¦ · Web viewAbiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of

Documents